<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>易凯资本 | wechat-feeds</title><link>http://MzI4MjA1OTcyMg.favicon.privacyhide.com/favicon.ico</link><description>易凯资本新闻资讯发布官方平台</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 10 Jun 2021 10:20:57 +0800</pubDate><image><url>http://MzI4MjA1OTcyMg.favicon.privacyhide.com/favicon.ico</url><title>易凯资本 | wechat-feeds</title><link>http://MzI4MjA1OTcyMg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>豪思生物完成2亿元B+轮融资，易凯资本担任独家财务顾问</title><link>https://mp.weixin.qq.com/s/9T5k8nAXUXUEBCWI-WrniA</link><description></description><content:encoded><![CDATA[豪思生物完成2亿元B+轮融资，易凯资本担任独家财务顾问]]></content:encoded><pubDate>Thu, 10 Jun 2021 07:59:21 +0800</pubDate></item><item><title>斯微生物完成2亿美元新一轮融资，易凯资本担任首席财务顾问</title><link>https://mp.weixin.qq.com/s/AxGXN__lfKn06w-UyHGdpg</link><description></description><content:encoded><![CDATA[斯微生物完成2亿美元新一轮融资，易凯资本担任首席财务顾问]]></content:encoded><pubDate>Thu, 03 Jun 2021 01:03:46 +0800</pubDate></item><item><title>2021易凯资本中国健康产业白皮书—健康产业并购篇</title><link>https://mp.weixin.qq.com/s/_2eaAu6M3I8_vg7gIwCJWw</link><description></description><content:encoded><![CDATA[2021易凯资本中国健康产业白皮书—健康产业并购篇]]></content:encoded><pubDate>Tue, 01 Jun 2021 09:59:49 +0800</pubDate></item><item><title>2021易凯资本中国健康产业白皮书—数字与AI健康篇</title><link>https://mp.weixin.qq.com/s/ajZTu9pkgdDXsGJIkhfZvw</link><description></description><content:encoded><![CDATA[2021易凯资本中国健康产业白皮书—数字与AI健康篇]]></content:encoded><pubDate>Mon, 31 May 2021 10:03:24 +0800</pubDate></item><item><title>2021易凯资本中国健康产业白皮书—医疗技术与器械篇</title><link>https://mp.weixin.qq.com/s/qo-iXxFtweumKDXFb1a63g</link><description></description><content:encoded><![CDATA[2021易凯资本中国健康产业白皮书—医疗技术与器械篇]]></content:encoded><pubDate>Fri, 28 May 2021 09:00:03 +0800</pubDate></item><item><title>2021易凯资本中国健康产业白皮书—医疗与健康服务篇</title><link>https://mp.weixin.qq.com/s/ih7dRzTUHfjuyU7IicPRGA</link><description></description><content:encoded><![CDATA[2021易凯资本中国健康产业白皮书—医疗与健康服务篇]]></content:encoded><pubDate>Thu, 27 May 2021 08:45:28 +0800</pubDate></item><item><title>2021易凯资本中国健康产业白皮书—医药与生物科技篇</title><link>https://mp.weixin.qq.com/s/FwulFGcoZ1vrKOTg7DHF5w</link><description></description><content:encoded><![CDATA[2021易凯资本中国健康产业白皮书—医药与生物科技篇]]></content:encoded><pubDate>Wed, 26 May 2021 10:06:33 +0800</pubDate></item><item><title>2021易凯资本中国健康产业白皮书—核心观点</title><link>https://mp.weixin.qq.com/s/VOZlhnbzOemuqfdQsTucDQ</link><description></description><content:encoded><![CDATA[2021易凯资本中国健康产业白皮书—核心观点]]></content:encoded><pubDate>Tue, 25 May 2021 07:59:20 +0800</pubDate></item><item><title>诊断的未来| CEC Lounge易凯来客</title><link>https://mp.weixin.qq.com/s/GJLnU4Mfm0fB181Lpyi1VQ</link><description></description><content:encoded><![CDATA[诊断的未来| CEC Lounge易凯来客]]></content:encoded><pubDate>Mon, 24 May 2021 15:00:09 +0800</pubDate></item><item><title>易凯资本被投企业文远知行完成数亿美元C轮融资</title><link>https://mp.weixin.qq.com/s/2F7jE2dR3iH5YEMxQOlA1w</link><description></description><content:encoded><![CDATA[易凯资本被投企业文远知行完成数亿美元C轮融资]]></content:encoded><pubDate>Thu, 13 May 2021 12:28:58 +0800</pubDate></item></channel></rss>